Lynx Dx has commercially launched MyProstateScore 2.0 (MPS2), a urine test kit for prostate cancer intended for at-home sample collection by patients. The test can be ordered by physicians and is ...
The launch follows research published in the Journal of Urology that found MPS2 delivers market-leading accuracy in predicting the risk of clinically significant prostate cancer even without ...
Feb. 20, 2025 /PRNewswire/ -- Lynx Dx, a leader in innovative diagnostic solutions, today announced the commercial launch of MyProstateScore 2.0 (MPS2) for at-home collection by patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback